Surmodics to Webcast Updated Fiscal 2016 Financial Guidance Conference Call on January 8
Webcast is Live at 7:30 a.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jan. 7, 2016--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and
in vitro diagnostic technologies to the healthcare industry, announced
today that it will host a live webcast on Friday, January 8, at 7:30
a.m. CT (8:30 a.m. ET), to provide updated financial guidance for full
fiscal year 2016. The Company will issue a news release earlier that
Gary Maharaj, president and chief executive officer, and Andy LaFrence,
vice president of finance and chief financial officer, will provide an
overview of fiscal 2016 guidance, which includes the Creagh Medical
acquisition, and will outline fiscal 2016 goals and long-term outlook
and the status of integration. To access the webcast, go to the investor
relations portion of the Company’s website at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 10:30 a.m. CT on Friday,
January 8, until 10:30 a.m. CT on Friday, January 15, and can be
accessed by dialing 888-203-1112 and entering conference call ID
passcode 2845259. In addition, the conference call audio and transcript
will be archived on the Company’s website following the call.
About Surmodics, Inc.
Surmodics partners with the world's leading and emerging medical device,
diagnostic and life sciences companies to develop and commercialize
innovative products designed to improve lives by enabling the detection
and treatment of disease. Our mission is to be a trusted partner to our
customers by providing the most advanced surface modification
technologies and in vitro diagnostic chemical components that
help enhance the well-being of patients. The company’s core offerings
include surface modification coating technologies that impart lubricity,
prohealing and biocompatibility characteristics and components for in
vitro diagnostic test kits and microarrays. Surmodics’ strategy is
to build on the product and technical leadership within these fields,
and expand the core offerings to generate opportunities for longer term
sustained growth. Surmodics is headquartered in Eden Prairie, Minnesota.
For more information about the Company, visit www.surmodics.com.
The content of Surmodics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160107005305/en/
Source: Surmodics, Inc.
Andy LaFrence, 952-500-7000